CVM Issues Warning Letter Over Alleged Claims Made for New Animal Drug

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

CVM Issues Warning Letter Over Alleged Claims Made for New Animal Drug

J.W. Schomisch

March 18, 2024 at 09:27 AM EST

In a rare Warning Letter, the Center for Veterinary Medicine (CVM) alleged Boehringer Ingelheim Animal Health USA made false and misleading claims and representations about the safety and effectiveness of Senvelgo (velagliflozin oral solution) on a product website. The March 1 Warning Letter said the “violation is especially concerning from a public health perspective because... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

CVM Issues Warning Letter Over Alleged Claims Made for New Animal Drug

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT